Transient CA19-9 Elevation Post-COVID-19 Vaccine and Infection: A Case Series

• S. Baydogan,
• R. Wright,
• R.T. Kottoor,
• M. Kim,
• M.S. Bhutani,
• F. McAllister

Affiliations

S. Baydogan

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas

R. Wright

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

R.T. Kottoor

Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

M. Kim

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas

M.S. Bhutani

Department of Gastroenterology, Hepatology, The University of Texas MD Anderson Cancer Center, Houston, Texas

F. McAllister

Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Clinical Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Correspondence: Address correspondence to: Florencia McAllister, MD, Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, 6767 Bertner Ave, Houston, Texas 77030.